loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 71787 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    ALRA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CLORAZEPATE DIPOTASSIUM (1)

    filter

    01 ALRA (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 3.75MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Clorazepate Dipotassium

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET;ORAL
      3.75MG
      GEN-XENE
      USA
      71787
      1988-04-26
      DISCN
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 71787

      Looking for CTD TGA MCC DOSSIER APPLICATION 71787 1

      19

      ALRA, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is CLORAZEPATE DIPOTASSIUM, with a corresponding application number 71787 and regulatory information .

      proudly manufactured in the

      approval since 1988-04-26

      ALRA's GEN-XENE TABLET;ORAL, medication with 3.75MG of CLORAZEPATE DIPOTASSIUM.

      Post Enquiry
      POST ENQUIRY